Methods of using sustained release aminopyridine compositions

Details for Australian Patent Application No. 2005232732 (hide)

Owner Acorda Therapeutics, Inc.

Inventors Cohen, Ron; Blight, Andrew R.; Marinucci, Lawrence

Agent Pizzeys

Pub. Number AU-B-2005232732

PCT Pub. Number WO2005/099701

Priority 60/560,894 09.04.04 US; 11/102,559 08.04.05 US

Filing date 11 April 2005

Wipo publication date 27 October 2005

Acceptance publication date 12 May 2011

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

Event Publications

25 January 2007 Section 223 Application Allowed

  Acorda Therapeutics, Inc. The time in which to enter the National Phase has been extended to 09 Dec 2006. Address for service in Australia - Pizzeys Level 2, Woden Plaza Offices Woden Town Square Woden ACT 2606 2006

1 February 2007 PCT application entered the National Phase

  PCT publication WO2005/099701 Priority application(s): WO2005/099701

12 May 2011 Application Accepted

  Published as AU-B-2005232732

8 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005232745-Polycyclic pyrimidines as potassium ion channel modulators

2005232726-Stent graft repair device